凯赛生物：2025年半年度净利润约3.09亿元，同比增加24.74%

Core Viewpoint - Kasei Biotech reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance and growth potential in the biotech industry [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 1.671 billion yuan, representing a year-on-year increase of 15.68% [2] - The net profit attributable to shareholders was around 309 million yuan, showing a year-on-year growth of 24.74% [2] - Basic earnings per share were reported at 0.47 yuan, which is an increase of 11.9% compared to the previous year [2]